These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. A comparative, randomized trial of concentration-controlled sirolimus combined with reduced-dose tacrolimus or standard-dose tacrolimus in renal allograft recipients. Bechstein WO, Paczek L, Wramner L, Squifflet JP, Zygmunt AJ, European Rapamune Tacrolimus Study Group. Transplant Proc; 2013 Feb 27; 45(6):2133-40. PubMed ID: 23953523 [Abstract] [Full Text] [Related]
12. Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study. Boillot O, Mayer DA, Boudjema K, Salizzoni M, Gridelli B, Filipponi F, Trunecka P, Krawczyk M, Clavien PA, Ducerf C, Margarit C, Margreiter R, Pallardo JM, Hoeckerstedt K, Pageaux GP. Liver Transpl; 2005 Jan 27; 11(1):61-7. PubMed ID: 15690537 [Abstract] [Full Text] [Related]
13. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation. Song JL, Gao W, Zhong Y, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Wu H, Xu MQ, Chen ZY, Wei YG, Jiang L, Yang J. World J Gastroenterol; 2016 Feb 14; 22(6):2133-41. PubMed ID: 26877618 [Abstract] [Full Text] [Related]
15. Intracellular ATP production in CD4+ T cells as a predictor for infection and allograft rejection in trough-level guided pediatric liver transplant recipients under calcineurin-inhibitor therapy. Schulz-Juergensen S, Burdelski MM, Oellerich M, Brandhorst G. Ther Drug Monit; 2012 Feb 14; 34(1):4-10. PubMed ID: 22210096 [Abstract] [Full Text] [Related]